HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension.

AbstractBACKGROUND:
Pulmonary arterial hypertension (PAH) is a progressive disease characterised by pro-proliferative and anti-apoptotic phenotype in vascular cells, leading to pulmonary vascular remodelling and right heart failure. Peptidyl-prolyl cis/trans isomerase, NIMA interacting 1 (Pin1), a highly conserved enzyme, which binds to and catalyses the isomerisation of specific phosphorylated Ser/Thr-Pro motifs, acts as a molecular switch in multiple coordinated cellular processes. We hypothesised that Pin1 plays a substantial role in PAH, and its inhibition with a natural organic compound, Juglone, would reverse experimental pulmonary hypertension.
RESULTS:
We demonstrated that the expression of Pin1 was markedly elevated in experimental pulmonary hypertension (i.e. hypoxia-induced mouse and Sugen/hypoxia-induced rat models) and pulmonary arterial smooth muscle cells of patients with clinical PAH. In vitro Pin1 inhibition by either Juglone treatment or short interfering RNA knockdown resulted in an induction of apoptosis and decrease in proliferation of human pulmonary vascular cells. Stimulation with growth factors induced Pin1 expression, while its inhibition reduced the activity of numerous PAH-related transcription factors, such as hypoxia-inducible factor (HIF)-α and signal transducer and activator of transcription (STAT). Juglone administration lowered pulmonary vascular resistance, enhanced right ventribular function, improved pulmonary vascular and cardiac remodelling in the Sugen/hypoxia rat model of PAH and the chronic hypoxia-induced pulmonary hypertension model in mice.
CONCLUSION:
Our study demonstrates that targeting of Pin1 with small molecule inhibitor, Juglone, might be an attractive future therapeutic strategy for PAH and right heart disease secondary to PAH.
AuthorsNabham Rai, Akylbek Sydykov, Baktybek Kojonazarov, Jochen Wilhelm, Grégoire Manaud, Swathi Veeroju, Clemens Ruppert, Frédéric Perros, Hossein Ardeschir Ghofrani, Norbert Weissmann, Werner Seeger, Ralph T Schermuly, Tatyana Novoyatleva
JournalThe European respiratory journal (Eur Respir J) Vol. 60 Issue 2 (08 2022) ISSN: 1399-3003 [Electronic] England
PMID35058248 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright ©The authors 2022.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • NIMA-Interacting Peptidylprolyl Isomerase
  • PDZD2 protein, rat
  • PIN1 protein, human
  • Peptidylprolyl Isomerase
  • Pin1 protein, mouse
Topics
  • Adaptor Proteins, Signal Transducing
  • Animals
  • Cell Proliferation
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Hypertension, Pulmonary (drug therapy)
  • Hypoxia
  • Mice
  • NIMA-Interacting Peptidylprolyl Isomerase
  • Peptidylprolyl Isomerase (genetics, metabolism)
  • Pulmonary Arterial Hypertension
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: